Abstract
The chronic fatigue syndrome (CFS) is characterized by severe persistent fatigue and neuropsychiatric symptoms. It has been proposed that the abnormalities in cell-mediated immunity which have been documented in patients with CFS may be attributable to a clinical depression, prevalent in patients with this disorder. Cell-mediated immune status was evaluated in patients with carefully defined CFS and compared with that of matched subjects with major depression (non-melancholic, non-psychotic) as well as healthy control subjects. Patients with CFS demonstrated impaired lymphocyte responses to phytohaemagglutinin (PHA) stimulation, and reduced or absent delayed-type hypersensitivity (DTH) skin responses when compared either with subjects with major depression or with healthy control subjects (P less than 0.05 for each analysis). Although depression is common in patients with CFS, the disturbances of cell-mediated immunity in this disorder differ in prevalence and magnitude from those associated with major depression. These observations strengthen the likelihood of a direct relationship between abnormal cell-mediated immunity and the etiology of CFS.
Full text
PDF



Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Arnold D. L., Bore P. J., Radda G. K., Styles P., Taylor D. J. Excessive intracellular acidosis of skeletal muscle on exercise in a patient with a post-viral exhaustion/fatigue syndrome. A 31P nuclear magnetic resonance study. Lancet. 1984 Jun 23;1(8391):1367–1369. doi: 10.1016/s0140-6736(84)91871-3. [DOI] [PubMed] [Google Scholar]
- Behan P. O., Behan W. M., Bell E. J. The postviral fatigue syndrome--an analysis of the findings in 50 cases. J Infect. 1985 May;10(3):211–222. doi: 10.1016/s0163-4453(85)92488-0. [DOI] [PubMed] [Google Scholar]
- Breder C. D., Dinarello C. A., Saper C. B. Interleukin-1 immunoreactive innervation of the human hypothalamus. Science. 1988 Apr 15;240(4850):321–324. doi: 10.1126/science.3258444. [DOI] [PubMed] [Google Scholar]
- Caligiuri M., Murray C., Buchwald D., Levine H., Cheney P., Peterson D., Komaroff A. L., Ritz J. Phenotypic and functional deficiency of natural killer cells in patients with chronic fatigue syndrome. J Immunol. 1987 Nov 15;139(10):3306–3313. [PubMed] [Google Scholar]
- Einhorn S., Blomgren H., Einhorn N., Strander H. In vitro and in vivo effects of interferon on the response of human lymphocytes to mitogens. Clin Exp Immunol. 1983 Feb;51(2):369–374. [PMC free article] [PubMed] [Google Scholar]
- Hamblin T. J., Hussain J., Akbar A. N., Tang Y. C., Smith J. L., Jones D. B. Immunological reason for chronic ill health after infectious mononucleosis. Br Med J (Clin Res Ed) 1983 Jul 9;287(6385):85–88. doi: 10.1136/bmj.287.6385.85. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hickie I., Lloyd A., Wakefield D., Parker G. The psychiatric status of patients with the chronic fatigue syndrome. Br J Psychiatry. 1990 Apr;156:534–540. doi: 10.1192/bjp.156.4.534. [DOI] [PubMed] [Google Scholar]
- Hickie I., Parker G., Wilhelm K., Tennant C. Perceived interpersonal risk factors of non-endogenous depression. Psychol Med. 1991 May;21(2):399–412. doi: 10.1017/s0033291700020511. [DOI] [PubMed] [Google Scholar]
- Hickie I., Silove D., Hickie C., Wakefield D., Lloyd A. Is there immune dysfunction in depressive disorders? Psychol Med. 1990 Nov;20(4):755–761. doi: 10.1017/s0033291700036424. [DOI] [PubMed] [Google Scholar]
- Immunological abnormalities in the chronic fatigue syndrome. Med J Aust. 1990 Jan 1;152(1):50–52. doi: 10.5694/j.1326-5377.1990.tb124435.x. [DOI] [PubMed] [Google Scholar]
- Klimas N. G., Salvato F. R., Morgan R., Fletcher M. A. Immunologic abnormalities in chronic fatigue syndrome. J Clin Microbiol. 1990 Jun;28(6):1403–1410. doi: 10.1128/jcm.28.6.1403-1410.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kniker W. T., Anderson C. T., McBryde J. L., Roumiantzeff M., Lesourd B. Multitest CMI for standardized measurement of delayed cutaneous hypersensitivity and cell-mediated immunity. Normal values and proposed scoring system for healthy adults in the U.S.A. Ann Allergy. 1984 Feb;52(2):75–82. [PubMed] [Google Scholar]
- Kronfol Z., Silva J., Jr, Greden J., Dembinski S., Gardner R., Carroll B. Impaired lymphocyte function in depressive illness. Life Sci. 1983 Jul 18;33(3):241–247. doi: 10.1016/0024-3205(83)90382-x. [DOI] [PubMed] [Google Scholar]
- Lloyd A. R., Gandevia S. C., Hales J. P. Muscle performance, voluntary activation, twitch properties and perceived effort in normal subjects and patients with the chronic fatigue syndrome. Brain. 1991 Feb;114(Pt 1A):85–98. [PubMed] [Google Scholar]
- Lloyd A. R., Hales J. P., Gandevia S. C. Muscle strength, endurance and recovery in the post-infection fatigue syndrome. J Neurol Neurosurg Psychiatry. 1988 Oct;51(10):1316–1322. doi: 10.1136/jnnp.51.10.1316. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Lloyd A. R., Hickie I., Boughton C. R., Spencer O., Wakefield D. Prevalence of chronic fatigue syndrome in an Australian population. Med J Aust. 1990 Nov 5;153(9):522–528. doi: 10.5694/j.1326-5377.1990.tb126191.x. [DOI] [PubMed] [Google Scholar]
- Lloyd A. R., Wakefield D., Boughton C. R., Dwyer J. M. Immunological abnormalities in the chronic fatigue syndrome. Med J Aust. 1989 Aug 7;151(3):122–124. doi: 10.5694/j.1326-5377.1989.tb139594.x. [DOI] [PubMed] [Google Scholar]
- Lloyd A. R., Wakefield D., Boughton C., Dwyer J. What is myalgic encephalomyelitis? Lancet. 1988 Jun 4;1(8597):1286–1287. doi: 10.1016/s0140-6736(88)92107-1. [DOI] [PubMed] [Google Scholar]
- McDonald E. M., Mann A. H., Thomas H. C. Interferons as mediators of psychiatric morbidity. An investigation in a trial of recombinant alpha-interferon in hepatitis-B carriers. Lancet. 1987 Nov 21;2(8569):1175–1178. doi: 10.1016/s0140-6736(87)91319-5. [DOI] [PubMed] [Google Scholar]
- Morrison L. J., Behan W. H., Behan P. O. Changes in natural killer cell phenotype in patients with post-viral fatigue syndrome. Clin Exp Immunol. 1991 Mar;83(3):441–446. doi: 10.1111/j.1365-2249.1991.tb05658.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Riley M. S., O'Brien C. J., McCluskey D. R., Bell N. P., Nicholls D. P. Aerobic work capacity in patients with chronic fatigue syndrome. BMJ. 1990 Oct 27;301(6758):953–956. doi: 10.1136/bmj.301.6758.953. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Rouse B. T., Horohov D. W. Immunosuppression in viral infections. Rev Infect Dis. 1986 Nov-Dec;8(6):850–873. doi: 10.1093/clinids/8.6.850. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Schattner A., Meshorer A., Wallach D. Involvement of interferon in virus-induced lymphopenia. Cell Immunol. 1983 Jul 1;79(1):11–25. doi: 10.1016/0008-8749(83)90046-1. [DOI] [PubMed] [Google Scholar]
- Schleifer S. J., Keller S. E., Bond R. N., Cohen J., Stein M. Major depressive disorder and immunity. Role of age, sex, severity, and hospitalization. Arch Gen Psychiatry. 1989 Jan;46(1):81–87. doi: 10.1001/archpsyc.1989.01810010083011. [DOI] [PubMed] [Google Scholar]
- Schleifer S. J., Keller S. E., Meyerson A. T., Raskin M. J., Davis K. L., Stein M. Lymphocyte function in major depressive disorder. Arch Gen Psychiatry. 1984 May;41(5):484–486. doi: 10.1001/archpsyc.1984.01790160070008. [DOI] [PubMed] [Google Scholar]
- Straus S. E., Tosato G., Armstrong G., Lawley T., Preble O. T., Henle W., Davey R., Pearson G., Epstein J., Brus I. Persisting illness and fatigue in adults with evidence of Epstein-Barr virus infection. Ann Intern Med. 1985 Jan;102(1):7–16. doi: 10.7326/0003-4819-102-1-7. [DOI] [PubMed] [Google Scholar]
- Toy J. L. The interferons. Clin Exp Immunol. 1983 Oct;54(1):1–13. [PMC free article] [PubMed] [Google Scholar]
- Wakefield D., Lloyd A. Pathophysiology of myalgic encephalitis. Lancet. 1987 Oct 17;2(8564):918–919. doi: 10.1016/s0140-6736(87)91408-5. [DOI] [PubMed] [Google Scholar]